T. Rowe Price Associates »

Arbutus Biopharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $75k 30k 2.52
2023-09-30 $55k 27k 2.06
2023-06-30 $59k 26k 2.30
2023-03-31 $66k 22k 3.07
2022-12-31 $47k 20k 2.34
2018-09-30 $4.7M 497k 9.45

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Arbutus Biopharma

Whitefort Capital Management
Vanguard Group
Hudson Bay Capital Management
ADAR1 Capital Management
Centiva Capital
Citadel Advisors
Millennium Management
Advisor Group Holdings
FourWorld Capital Management
Citigroup
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Barclays
Bank Of Montreal

View all funds holding Arbutus Biopharma